Artificial intelligence in medicine is the use of machine learning models to search medical data and uncover insights to help improve health outcomes and patient experiences. Thanks to recent advances in computer science and informatics, artificial intelligence (AI) is quickly becoming an integral part of modern healthcare. AI algorithms and other applications powered by AI are being used to support medical professionals in clinical settings and in ongoing research. Currently, the most common roles for AI in medical settings are clinical decision support and imaging analysis. Clinical decision support tools help providers make decisions about treatments, medications, mental health and other patient needs by providing them with quick access to information or research that's relevant to their patient.
Drug discovery is often one of the longest and most costly parts of drug development. AI could help reduce the costs of developing new medicines in primarily two ways: creating better drug designs and finding promising new drug combinations. With AI, many of the big data challenges facing the life sciences industry could be overcome.
Market Analysis and Insights: Global Artificial Intelligence in Drug Discovery Market
The global Artificial Intelligence in Drug Discovery market is projected to grow from US$ 1787 million in 2024 to US$ 8908 million by 2030, at a Compound Annual Growth Rate (CAGR) of 30.7% during the forecast period.
The key manufacturers of Artificial Intelligence in Drug Discovery include IBM, Google (Alphabet), Atomwise, Schrodinger, Microsoft, etc. The top five players have a combined market share of about 19%.
North America is the world's largest market, accounting for about 46%. It is followed by Europe and Asia, each with about 25%. The Asian market is slowly expanding.
The application of Artificial Intelligence in Drug Discovery mainly includes hardware, software and service. Hardware is by far the most widely used, with a market share of about 53%. The market share of software types is expected to increase further.
Early drug discovery, preclinical phase, clinical phase, and regulatory approval are the main application stages. The current preclinical market share is about 38%, and it is expected to be more widely used in the preclinical stage in the future.
Report Covers:
This report presents an overview of global market for Artificial Intelligence in Drug Discovery market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Artificial Intelligence in Drug Discovery, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence in Drug Discovery, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Intelligence in Drug Discovery revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Artificial Intelligence in Drug Discovery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Artificial Intelligence in Drug Discovery revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals, Inc
Segment by Type
Hardware
Software
Service
Segment by Application
Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Intelligence in Drug Discovery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Drug Discovery companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Drug Discovery revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Hardware
1.2.3 Software
1.2.4 Service
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Drug Discovery Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Early Drug Discovery
1.3.3 Preclinical Phase
1.3.4 Clinical Phase
1.3.5 Regulatory Approval
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Drug Discovery Market Perspective (2019-2030)
2.2 Global Artificial Intelligence in Drug Discovery Growth Trends by Region
2.2.1 Artificial Intelligence in Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence in Drug Discovery Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence in Drug Discovery Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence in Drug Discovery Market Dynamics
2.3.1 Artificial Intelligence in Drug Discovery Industry Trends
2.3.2 Artificial Intelligence in Drug Discovery Market Drivers
2.3.3 Artificial Intelligence in Drug Discovery Market Challenges
2.3.4 Artificial Intelligence in Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artificial Intelligence in Drug Discovery by Players
3.1.1 Global Artificial Intelligence in Drug Discovery Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence in Drug Discovery Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence in Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Intelligence in Drug Discovery, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Drug Discovery Revenue in 2023
3.5 Global Key Players of Artificial Intelligence in Drug Discovery Head office and Area Served
3.6 Global Key Players of Artificial Intelligence in Drug Discovery, Product and Application
3.7 Global Key Players of Artificial Intelligence in Drug Discovery, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Drug Discovery Breakdown Data by Type
4.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence in Drug Discovery Breakdown Data by Application
5.1 Global Artificial Intelligence in Drug Discovery Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence in Drug Discovery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence in Drug Discovery Market Size (2019-2030)
6.2 North America Artificial Intelligence in Drug Discovery Market Size by Type
6.2.1 North America Artificial Intelligence in Drug Discovery Market Size by Type (2019-2024)
6.2.2 North America Artificial Intelligence in Drug Discovery Market Size by Type (2025-2030)
6.2.3 North America Artificial Intelligence in Drug Discovery Market Share by Type (2019-2030)
6.3 North America Artificial Intelligence in Drug Discovery Market Size by Application
6.3.1 North America Artificial Intelligence in Drug Discovery Market Size by Application (2019-2024)
6.3.2 North America Artificial Intelligence in Drug Discovery Market Size by Application (2025-2030)
6.3.3 North America Artificial Intelligence in Drug Discovery Market Share by Application (2019-2030)
6.4 North America Artificial Intelligence in Drug Discovery Market Size by Country
6.4.1 North America Artificial Intelligence in Drug Discovery Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
6.4.3 North America Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Artificial Intelligence in Drug Discovery Market Size (2019-2030)
7.2 Europe Artificial Intelligence in Drug Discovery Market Size by Type
7.2.1 Europe Artificial Intelligence in Drug Discovery Market Size by Type (2019-2024)
7.2.2 Europe Artificial Intelligence in Drug Discovery Market Size by Type (2025-2030)
7.2.3 Europe Artificial Intelligence in Drug Discovery Market Share by Type (2019-2030)
7.3 Europe Artificial Intelligence in Drug Discovery Market Size by Application
7.3.1 Europe Artificial Intelligence in Drug Discovery Market Size by Application (2019-2024)
7.3.2 Europe Artificial Intelligence in Drug Discovery Market Size by Application (2025-2030)
7.3.3 Europe Artificial Intelligence in Drug Discovery Market Share by Application (2019-2030)
7.4 Europe Artificial Intelligence in Drug Discovery Market Size by Country
7.4.1 Europe Artificial Intelligence in Drug Discovery Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
7.4.3 Europe Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artificial Intelligence in Drug Discovery Market Size (2019-2030)
8.2 China Artificial Intelligence in Drug Discovery Market Size by Type
8.2.1 China Artificial Intelligence in Drug Discovery Market Size by Type (2019-2024)
8.2.2 China Artificial Intelligence in Drug Discovery Market Size by Type (2025-2030)
8.2.3 China Artificial Intelligence in Drug Discovery Market Share by Type (2019-2030)
8.3 China Artificial Intelligence in Drug Discovery Market Size by Application
8.3.1 China Artificial Intelligence in Drug Discovery Market Size by Application (2019-2024)
8.3.2 China Artificial Intelligence in Drug Discovery Market Size by Application (2025-2030)
8.3.3 China Artificial Intelligence in Drug Discovery Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Artificial Intelligence in Drug Discovery Market Size (2019-2030)
9.2 Asia Artificial Intelligence in Drug Discovery Market Size by Type
9.2.1 Asia Artificial Intelligence in Drug Discovery Market Size by Type (2019-2024)
9.2.2 Asia Artificial Intelligence in Drug Discovery Market Size by Type (2025-2030)
9.2.3 Asia Artificial Intelligence in Drug Discovery Market Share by Type (2019-2030)
9.3 Asia Artificial Intelligence in Drug Discovery Market Size by Application
9.3.1 Asia Artificial Intelligence in Drug Discovery Market Size by Application (2019-2024)
9.3.2 Asia Artificial Intelligence in Drug Discovery Market Size by Application (2025-2030)
9.3.3 Asia Artificial Intelligence in Drug Discovery Market Share by Application (2019-2030)
9.4 Asia Artificial Intelligence in Drug Discovery Market Size by Region
9.4.1 Asia Artificial Intelligence in Drug Discovery Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Artificial Intelligence in Drug Discovery Market Size by Region (2019-2024)
9.4.3 Asia Artificial Intelligence in Drug Discovery Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Artificial Intelligence in Drug Discovery Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence in Drug Discovery Introduction
11.1.4 IBM Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.1.5 IBM Recent Developments
11.2 Exscientia
11.2.1 Exscientia Company Details
11.2.2 Exscientia Business Overview
11.2.3 Exscientia Artificial Intelligence in Drug Discovery Introduction
11.2.4 Exscientia Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.2.5 Exscientia Recent Developments
11.3 Google(Alphabet)
11.3.1 Google(Alphabet) Company Details
11.3.2 Google(Alphabet) Business Overview
11.3.3 Google(Alphabet) Artificial Intelligence in Drug Discovery Introduction
11.3.4 Google(Alphabet) Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.3.5 Google(Alphabet) Recent Developments
11.4 Microsoft
11.4.1 Microsoft Company Details
11.4.2 Microsoft Business Overview
11.4.3 Microsoft Artificial Intelligence in Drug Discovery Introduction
11.4.4 Microsoft Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.4.5 Microsoft Recent Developments
11.5 Atomwise
11.5.1 Atomwise Company Details
11.5.2 Atomwise Business Overview
11.5.3 Atomwise Artificial Intelligence in Drug Discovery Introduction
11.5.4 Atomwise Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.5.5 Atomwise Recent Developments
11.6 Schrodinger
11.6.1 Schrodinger Company Details
11.6.2 Schrodinger Business Overview
11.6.3 Schrodinger Artificial Intelligence in Drug Discovery Introduction
11.6.4 Schrodinger Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.6.5 Schrodinger Recent Developments
11.7 Aitia
11.7.1 Aitia Company Details
11.7.2 Aitia Business Overview
11.7.3 Aitia Artificial Intelligence in Drug Discovery Introduction
11.7.4 Aitia Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.7.5 Aitia Recent Developments
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence in Drug Discovery Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.8.5 Insilico Medicine Recent Developments
11.9 NVIDIA
11.9.1 NVIDIA Company Details
11.9.2 NVIDIA Business Overview
11.9.3 NVIDIA Artificial Intelligence in Drug Discovery Introduction
11.9.4 NVIDIA Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.9.5 NVIDIA Recent Developments
11.10 XtalPi
11.10.1 XtalPi Company Details
11.10.2 XtalPi Business Overview
11.10.3 XtalPi Artificial Intelligence in Drug Discovery Introduction
11.10.4 XtalPi Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.10.5 XtalPi Recent Developments
11.11 BPGbio
11.11.1 BPGbio Company Details
11.11.2 BPGbio Business Overview
11.11.3 BPGbio Artificial Intelligence in Drug Discovery Introduction
11.11.4 BPGbio Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.11.5 BPGbio Recent Developments
11.12 Owkin
11.12.1 Owkin Company Details
11.12.2 Owkin Business Overview
11.12.3 Owkin Artificial Intelligence in Drug Discovery Introduction
11.12.4 Owkin Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.12.5 Owkin Recent Developments
11.13 CytoReason
11.13.1 CytoReason Company Details
11.13.2 CytoReason Business Overview
11.13.3 CytoReason Artificial Intelligence in Drug Discovery Introduction
11.13.4 CytoReason Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.13.5 CytoReason Recent Developments
11.14 Deep Genomics
11.14.1 Deep Genomics Company Details
11.14.2 Deep Genomics Business Overview
11.14.3 Deep Genomics Artificial Intelligence in Drug Discovery Introduction
11.14.4 Deep Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.14.5 Deep Genomics Recent Developments
11.15 Cloud Pharmaceuticals
11.15.1 Cloud Pharmaceuticals Company Details
11.15.2 Cloud Pharmaceuticals Business Overview
11.15.3 Cloud Pharmaceuticals Artificial Intelligence in Drug Discovery Introduction
11.15.4 Cloud Pharmaceuticals Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.15.5 Cloud Pharmaceuticals Recent Developments
11.16 BenevolentAI
11.16.1 BenevolentAI Company Details
11.16.2 BenevolentAI Business Overview
11.16.3 BenevolentAI Artificial Intelligence in Drug Discovery Introduction
11.16.4 BenevolentAI Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.16.5 BenevolentAI Recent Developments
11.17 Cyclica
11.17.1 Cyclica Company Details
11.17.2 Cyclica Business Overview
11.17.3 Cyclica Artificial Intelligence in Drug Discovery Introduction
11.17.4 Cyclica Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.17.5 Cyclica Recent Developments
11.18 Verge Genomics
11.18.1 Verge Genomics Company Details
11.18.2 Verge Genomics Business Overview
11.18.3 Verge Genomics Artificial Intelligence in Drug Discovery Introduction
11.18.4 Verge Genomics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.18.5 Verge Genomics Recent Developments
11.19 Valo Health
11.19.1 Valo Health Company Details
11.19.2 Valo Health Business Overview
11.19.3 Valo Health Artificial Intelligence in Drug Discovery Introduction
11.19.4 Valo Health Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.19.5 Valo Health Recent Developments
11.20 Envisagenics
11.20.1 Envisagenics Company Details
11.20.2 Envisagenics Business Overview
11.20.3 Envisagenics Artificial Intelligence in Drug Discovery Introduction
11.20.4 Envisagenics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.20.5 Envisagenics Recent Developments
11.21 Euretos
11.21.1 Euretos Company Details
11.21.2 Euretos Business Overview
11.21.3 Euretos Artificial Intelligence in Drug Discovery Introduction
11.21.4 Euretos Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.21.5 Euretos Recent Developments
11.22 BioAge Labs
11.22.1 BioAge Labs Company Details
11.22.2 BioAge Labs Business Overview
11.22.3 BioAge Labs Artificial Intelligence in Drug Discovery Introduction
11.22.4 BioAge Labs Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.22.5 BioAge Labs Recent Developments
11.23 Iktos
11.23.1 Iktos Company Details
11.23.2 Iktos Business Overview
11.23.3 Iktos Artificial Intelligence in Drug Discovery Introduction
11.23.4 Iktos Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.23.5 Iktos Recent Developments
11.24 BioSymetrics
11.24.1 BioSymetrics Company Details
11.24.2 BioSymetrics Business Overview
11.24.3 BioSymetrics Artificial Intelligence in Drug Discovery Introduction
11.24.4 BioSymetrics Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.24.5 BioSymetrics Recent Developments
11.25 Evaxion Biotech
11.25.1 Evaxion Biotech Company Details
11.25.2 Evaxion Biotech Business Overview
11.25.3 Evaxion Biotech Artificial Intelligence in Drug Discovery Introduction
11.25.4 Evaxion Biotech Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.25.5 Evaxion Biotech Recent Developments
11.26 Aria Pharmaceuticals, Inc
11.26.1 Aria Pharmaceuticals, Inc Company Details
11.26.2 Aria Pharmaceuticals, Inc Business Overview
11.26.3 Aria Pharmaceuticals, Inc Artificial Intelligence in Drug Discovery Introduction
11.26.4 Aria Pharmaceuticals, Inc Revenue in Artificial Intelligence in Drug Discovery Business (2019-2024)
11.26.5 Aria Pharmaceuticals, Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals, Inc
听
听
*If Applicable.
